Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis

Abstract

Adverse reactions with DMSO-cryopreserved stem cell infusion are well-recognized. However, severe, life-threatening anaphylactic reactions with DMSO are very rarely described in the literature. We report here a 58-year-old female with AL amyloidosis who developed an unexpected episode of respiratory arrest a few seconds after the beginning of thawed stem cell product infusion. Fortunately, the patient was resuscitated successfully without the need for intubation. The prompt development of the reaction just a few seconds after the stem cell infusion convincingly implicates DMSO as the potential suspect. The presence of amyloid cardiomyopathy might have also contributed to this adverse event. Bone Marrow Transplantation (2000) 25, 1299–1301.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Gertz MA . Amyloidosis: recognition, prognosis and conventional therapy. In: Schechter GP, Hoffman R, Schrier SL (eds) Hematology American Society of Hematology Education Program Book 1999 pp339–347

    Google Scholar 

  2. Saba N, Sutton DM, Ross HJ et al. High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant Bone Marrow Transplant 1999 24: 853–855

    Article  CAS  Google Scholar 

  3. Kyle RA . High-dose therapy in multiple myeloma and primary amyloidosis: an overview Semin Oncol 1999 26: 74–83

    CAS  PubMed  Google Scholar 

  4. Comenzo RL . High-dose therapy for the treatment of primary systemic amyloidosis. In: Schechter GP, Hoffman R, Schrier SL (eds) Hematology American Society of Hematology Education Program Book 1999 pp347–357

    Google Scholar 

  5. Comenzo RL, Vosburgh E, Falk RH et al. Dose-intensive melphalan with blood stem cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients Blood 1998 91: 3662–3670

    CAS  PubMed  Google Scholar 

  6. Comenzo RL, Sanchorawala V, Fisher C et al. Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light-chain) amyloidosis Br J Haematol 1999 104: 553–559

    Article  CAS  Google Scholar 

  7. Egorin MJ, Rosen DM, Sridhara R et al. Plasma concentrations and pharmacokinetics of dimethylsulfoxide and its metabolites in patients undergoing peripheral blood stem cell transplants J Clin Oncol 1998 16: 610–615

    Article  CAS  Google Scholar 

  8. Alessandrino P, Bernasconi P, Caldera D et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases Bone Marrow Transplant 1999 23: 533–537

    Article  CAS  Google Scholar 

  9. Davis J, Rowley SD, Braine HG et al. Clinical toxicity of cryopreserved bone marrow graft infusion Blood 1990 75: 781–786

    CAS  PubMed  Google Scholar 

  10. Rapoport AP, Rowe JM, Packman CH, Ginsberg SJ . Cardiac arrest after autologous marrow infusion Bone Marrow Transplant 1991 7: 401–403

    CAS  PubMed  Google Scholar 

  11. Roy V, Veys P, Jackson F et al. Adult respiratory syndrome following autologous bone marrow transfusion Bone Marrow Transplant 1989 4: 711–712

    CAS  PubMed  Google Scholar 

  12. Nishihara G, Sakemi T, Ikeda Y et al. Multiple organ failure associated with dimethylsulfoxide and hydroxyethyl starch in autologous blood stem cell transplantation Nephron 1996 72: 356–357

    Article  CAS  Google Scholar 

  13. Miniero R, Vai S, Giacchino M et al. Severe respiratory depression after autologous bone marrow infusion Haematologica 1992 77: 98–99

    CAS  PubMed  Google Scholar 

  14. Vriesendorp R, Aalders JG, Sleijfer DTh et al. Effective high-dose chemotherapy with autologous bone marrow infusion in resistant ovarian cancer Gynecol Oncol 1984 17: 271–276

    Article  CAS  Google Scholar 

  15. Hameroff SR, Otto CW, Kanel J et al. Acute cardiovascular effects of dimethylsulfoxide Crit Care Med 1981 9: 855–857

    Article  CAS  Google Scholar 

  16. Kligman AM . Topical pharmacology and toxicology of dimethylsulfoxide JAMA 1965 193: 796–804

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benekli, M., Anderson, B., Wentling, D. et al. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant 25, 1299–1301 (2000). https://doi.org/10.1038/sj.bmt.1702452

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702452

Keywords

This article is cited by

Search

Quick links